StockData
BioRestorative Therapies, Inc. logo

BioRestorative Therapies, Inc. (BRTX) stock

BRTXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 14, 2026Score 8/30
$1.42−0.07 (-4.70%)

Close on Nov 16, 2026Market cap $36.18MP/E –Yield –

BioRestorative Therapies total assets

Total assets on the balance sheet at the end of each period.

BioRestorative Therapies's total assets was $4.64M at Mar 31, 2026. For fiscal 2025 it was $4.08M, down 66.8% from the year before. Over ten years it grew 7.3% a year on average. The highest annual figure on record is $22.45M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.08M-66.8%
FY2024Dec 31, 2024$12.28M-2.6%
FY2023Dec 31, 2023$12.61M-23.3%
FY2022Dec 31, 2022$16.43M-26.8%
FY2021Dec 31, 2021$22.45M+416.5%
FY2020Dec 31, 2020$4.35M+196.5%
FY2019Dec 31, 2019$1.47M+23.0%
FY2018Dec 31, 2018$1.19M-32.2%
FY2017Dec 31, 2017$1.76M+11.3%
FY2016Dec 31, 2016$1.58M-21.7%
FY2015Dec 31, 2015$2.02M+19.2%
FY2014Dec 31, 2014$1.69M+22.3%
FY2013Dec 31, 2013$1.38M+9.1%
FY2012Dec 31, 2012$1.27M+473.8%
FY2011Dec 31, 2011$220.97K-52.8%
FY2010Dec 31, 2010$468.51K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2026Mar 31, 2026$4.64M-55.1%
Q4 FY2025Dec 31, 2025$4.08M-66.8%
Q3 FY2025Sep 30, 2025$5.64M-61.3%
Q2 FY2025Jun 30, 2025$8.52M-47.2%
Q1 FY2025Mar 31, 2025$10.33M-42.5%
Q4 FY2024Dec 31, 2024$12.28M-2.6%
Q3 FY2024Sep 30, 2024$14.57M+5.6%
Q2 FY2024Jun 30, 2024$16.12M+21.2%
Q1 FY2024Mar 31, 2024$17.95M+27.5%
Q4 FY2023Dec 31, 2023$12.61M-23.3%
Q3 FY2023Sep 30, 2023$13.80M-23.0%
Q2 FY2023Jun 30, 2023$13.30M-31.6%
Q1 FY2023Mar 31, 2023$14.08M-32.7%
Q4 FY2022Dec 31, 2022$16.43M-26.8%
Q3 FY2022Sep 30, 2022$17.92M+723.9%
Q2 FY2022Jun 30, 2022$19.44M+573.9%
Q1 FY2022Mar 31, 2022$20.92M+465.2%
Q4 FY2021Dec 31, 2021$22.45M+416.5%
Q3 FY2021Sep 30, 2021$2.18M+52.2%
Q2 FY2021Jun 30, 2021$2.88M+78.8%
Q1 FY2021Mar 31, 2021$3.70M+168.7%
Q4 FY2020Dec 31, 2020$4.35M+196.5%
Q3 FY2020Sep 30, 2020$1.43M-2.0%
Q2 FY2020Jun 30, 2020$1.61M-33.7%
Q1 FY2020Mar 31, 2020$1.38M-13.0%
Q4 FY2019Dec 31, 2019$1.47M+23.0%
Q3 FY2019Sep 30, 2019$1.46M+16.6%
Q2 FY2019Jun 30, 2019$2.43M+101.7%
Q1 FY2019Mar 31, 2019$1.58M+29.5%
Q4 FY2018Dec 31, 2018$1.19M-32.2%
Q3 FY2018Sep 30, 2018$1.25M-11.8%
Q2 FY2018Jun 30, 2018$1.21M-15.3%
Q1 FY2018Mar 31, 2018$1.22M-17.4%
Q4 FY2017Dec 31, 2017$1.76M+11.3%
Q3 FY2017Sep 30, 2017$1.42M-12.2%
Q2 FY2017Jun 30, 2017$1.42M-35.2%
Q1 FY2017Mar 31, 2017$1.48M–
Q4 FY2016Dec 31, 2016$1.58M–
Q3 FY2016Sep 30, 2016$1.62M–
Q2 FY2016Jun 30, 2016$2.20M–

More BioRestorative Therapies figures

See a number that looks wrong?